Department of Chemistry, Sungkyunkwan University, Suwon, Korea.
OliX Pharmaceuticals, Inc., Suwon, Korea.
Nucleic Acid Ther. 2019 Oct;29(5):291-299. doi: 10.1089/nat.2019.0778. Epub 2019 Jul 17.
RNA interference (RNAi) offers great promise in life science research and therapeutic development, as it easily achieves a potent target gene knockdown with high specificity. Since the conventional small interfering RNA (siRNA) structure, known as 19 bp double-stranded RNA (dsRNA) with 2-nucleotide (nt) 3' overhang, has been introduced to successfully elicit the RNAi in mammalian cells, a variety of structural variants of RNAi trigger have been developed. Our group previously reported branched, tripodal interfering RNA (tiRNA) structures as a multigene targeting RNA structure inducing RNAi. However, the immune stimulatory effect of branched tiRNA structure has not been thoroughly evaluated. In this study, we show that tiRNA with blunt ends triggers innate immune response in T98G cell and mouse macrophage cells, which is dependent upon the retinoic acid-inducible gene I (RIG-I), a well-known cytoplasmic dsRNA sensor. Interestingly, immune response triggered by tiRNA can be suppressed by the introduction of 2-nt 3' overhang structure. Our finding expands the structural diversity of RIG-I ligands and provides a guide to develop a safe multitargeting RNA structure for therapeutic application.
RNA 干扰 (RNAi) 在生命科学研究和治疗开发方面具有巨大的应用潜力,因为它可以轻松实现高特异性的强效靶基因敲低。自从传统的小干扰 RNA (siRNA) 结构,即具有 2 个核苷酸 (nt) 3' 突出的 19 个核苷酸 (nt) 双链 RNA (dsRNA),被引入到哺乳动物细胞中成功引发 RNAi 以来,已经开发出了各种结构变体的 RNAi 触发物。我们的研究小组之前报道了分支、三臂干扰 RNA (tiRNA) 结构作为一种多基因靶向 RNA 结构诱导 RNAi。然而,分支 tiRNA 结构的免疫刺激性作用尚未得到彻底评估。在这项研究中,我们表明具有平头末端的 tiRNA 在 T98G 细胞和小鼠巨噬细胞中引发先天免疫反应,这依赖于视黄酸诱导基因 I (RIG-I),一种已知的细胞质 dsRNA 传感器。有趣的是,tiRNA 引发的免疫反应可以通过引入 2 个核苷酸 3' 突出结构来抑制。我们的发现扩展了 RIG-I 配体的结构多样性,并为开发用于治疗应用的安全的多靶向 RNA 结构提供了指导。